Canada markets close in 3 hours 22 minutes

Globus Medical, Inc. (GMED)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
50.24-1.20 (-2.33%)
As of 12:38PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.96B
Enterprise Value 6.97B
Trailing P/E 48.07
Forward P/E 19.16
PEG Ratio (5 yr expected) 1.74
Price/Sales (ttm)3.76
Price/Book (mrq)1.74
Enterprise Value/Revenue 4.44
Enterprise Value/EBITDA 20.10

Trading Information

Stock Price History

Beta (5Y Monthly) 1.10
52-Week Change 3-10.59%
S&P500 52-Week Change 322.64%
52 Week High 362.88
52 Week Low 343.39
50-Day Moving Average 353.07
200-Day Moving Average 352.58

Share Statistics

Avg Vol (3 month) 31.04M
Avg Vol (10 day) 3927.77k
Shares Outstanding 5112.94M
Implied Shares Outstanding 6135.37M
Float 8111.92M
% Held by Insiders 10.79%
% Held by Institutions 197.32%
Shares Short (Apr 15, 2024) 47.51M
Short Ratio (Apr 15, 2024) 47.36
Short % of Float (Apr 15, 2024) 46.70%
Short % of Shares Outstanding (Apr 15, 2024) 45.55%
Shares Short (prior month Mar 15, 2024) 45.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 7.83%
Operating Margin (ttm)12.74%

Management Effectiveness

Return on Assets (ttm)4.77%
Return on Equity (ttm)4.21%

Income Statement

Revenue (ttm)1.57B
Revenue Per Share (ttm)13.87
Quarterly Revenue Growth (yoy)124.60%
Gross Profit (ttm)N/A
EBITDA 418.24M
Net Income Avi to Common (ttm)122.87M
Diluted EPS (ttm)1.07
Quarterly Earnings Growth (yoy)-70.00%

Balance Sheet

Total Cash (mrq)517.79M
Total Cash Per Share (mrq)3.83
Total Debt (mrq)521.22M
Total Debt/Equity (mrq)13.04%
Current Ratio (mrq)4.88
Book Value Per Share (mrq)29.32

Cash Flow Statement

Operating Cash Flow (ttm)243.5M
Levered Free Cash Flow (ttm)-346.92M